Home :: Media :: Articles :: Articles
Articles

DocumentsDate added

Order by : Name | Date | Hits [ Ascendant ]

Scripps Florida Team Awarded Nearly $1.5 Million to Develop Potent New HIV Inhibitors

February 27, 2012

A Scripps Florida team has been awarded nearly $1.5 million by the National Institutes of Health to identify and develop novel potent inhibitors of the human immunodeficiency virus (HIV), the cause of AIDS.

A. Donny Strosberg, a professor on the Florida campus of The Scripps Research Institute, is the principal investigator for the new three-year study.

 March 9, 2009

A team from The Scripps Research Institute has found a way to inhibit viral production of the Hepatitis C virus (HCV). The advance has the potential to accelerate future research on the virus life cycle and to aid in the development of novel HVC drugs.

Scientists from the Scripps Florida campus of The Scripps Research Institute and their colleagues at Boston University have described their discovery of several novel drug-like inhibitors of the hepatitis C virus (HCV). These new inhibitors have the potential to substantially widen the current options to treat HCV infection.

The research, from the laboratory of Professor Donny Strosberg of Scripps Florida, supported by members of the Scripps Florida Lead Discovery Division directed by Peter Hodder, and colleagues from Boston University, will be published in an upcoming print edition of the journal ASSAY and Drug Development Technologies and appeared in the December 15, 2009 print edition of the journal Bioorganic & Medicinal Chemistry Letters.

Discovery Opens Door to Research on New Type of Therapeutic Compounds

Jupiter, FL, December 16, 2009 – Scientists from the Scripps Florida campus of The Scripps Research Institute and their colleagues at Boston University have described their discovery of several novel drug-like inhibitors of the hepatitis C virus (HCV). These new inhibitors have the potential to substantially widen the current options to treat HCV infection.

Challenges can make people crumble and surrender or spur them to fight harder to succeed.

Donny Strosberg, a biochemist at The Scripps Research Institute\'s Florida campus in Jupiter, falls into the later category.

A professor in the department of infectology, Strosberg has experienced his share of challenges — what he calls head winds — but those obstacles have not been able to dampen the hearty enthusiasm he has for his research, his family and life.

Pharmaceutical